At the time of writing, Cg Oncology Inc [CGON] stock is trading at $27.97, up 25.03%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CGON shares have gain 37.04% over the last week, with a monthly amount glided 3.82%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cg Oncology Inc [NASDAQ: CGON] stock has seen the most recent analyst activity on April 16, 2025, when Scotiabank initiated its Sector Perform rating and assigned the stock a price target of $23. On October 24, 2024, UBS initiated with a Buy rating and assigned a price target of $60 on the stock. RBC Capital Mkts started tracking the stock assigning a Outperform rating and suggested a price target of $66 on September 23, 2024. ROTH MKM initiated its recommendation with a Buy and recommended $65 as its price target on August 28, 2024. BofA Securities started tracking with a Buy rating for this stock on June 28, 2024, and assigned it a price target of $65. In a note dated February 20, 2024, Morgan Stanley initiated an Overweight rating and provided a target price of $55 on this stock.
For the past year, the stock price of Cg Oncology Inc fluctuated between $14.80 and $46.99. Currently, Wall Street analysts expect the stock to reach $55 within the next 12 months. Cg Oncology Inc [NASDAQ: CGON] shares were valued at $27.97 at the most recent close of the market. An investor can expect a potential return of 96.64% based on the average CGON price forecast.
Analyzing the CGON fundamentals
According to Cg Oncology Inc [NASDAQ:CGON], the company’s sales were 1.14M for trailing twelve months, which represents an 45500.00% jump. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -100.67%, Pretax Profit Margin comes in at -77.29%, and Net Profit Margin reading is -77.29%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.15 and Total Capital is -0.16. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.26 points at the first support level, and at 24.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 30.99, and for the 2nd resistance point, it is at 34.01.
Ratios To Look Out For
It is important to note that Cg Oncology Inc [NASDAQ:CGON] has a current ratio of 35.30. Further, the Quick Ratio stands at 35.30, while the Cash Ratio is 12.03. Considering the valuation of this stock, the price to sales ratio is 1869.99, the price to book ratio is 2.90.
Transactions by insiders
Recent insider trading involved POST LEONARD E, Director, that happened on Mar 17 ’25 when 1000.0 shares were sold. Director, LEONARD E POST completed a deal on Mar 17 ’25 to buy 4000.0 shares. Meanwhile, Director POST LEONARD E sold 1000.0 shares on Feb 18 ’25.
